SNTI Senti Biosciences Holdings, Inc.: institutional ownership and insider trading
18 funds reported holding $1.24M of Senti Biosciences Holdings, Inc. in their latest 13F filings; in Q2 2026 funds net bought $1.24M, with 18 new positions and 0 funds selling out; over the last 12 months insiders bought $0 and sold $0 on the open market.
Famous investors holding SNTI
- Ken Griffin (Citadel Advisors): $118K, 0.0% of the portfolio
Largest institutional holders of SNTI
- VANGUARD CAPITAL MANAGEMENT LLC — $591K
- GEODE CAPITAL MANAGEMENT, LLC — $206K
- CITADEL ADVISORS LLC — $118K
- VANGUARD FIDUCIARY TRUST CO — $100K
- JANE STREET GROUP, LLC — $57.8K
- Menlo Ventures Management, L.P. — $39.3K
- NORTHERN TRUST CORP (NTRS, NTRSO) — $35.4K
- XTX Topco Ltd — $26.0K
- Virtu Financial LLC — $25.0K
- UBS Group AG (UBS) — $15.9K
Recent SNTI insider trades
- Feb 6, 2025: Lu Timothy K sold 4,467 shares ($18.3K)
- Feb 6, 2025: Rajangam Kanya sold 1,479 shares ($6.07K)
5%+ owners
- Celadon Partners SPV 24: 54.6% (Schedule 13D/A, filed Sep 11, 2026)